NCT00965978View on ClinicalTrials.gov

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
OsteoporosisOsteoporosis, PostmenopausalBone Diseases
Interventions
DRUG

ONO-5920 / YM529

oral

Trial Locations (1)

Unknown

Kantou

Sponsors

Collaborators (1)

Ono Pharma USA Inc
All Listed Sponsors
collaborator

Ono Pharma USA Inc

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY